Compare TRIP & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRIP | BLFS |
|---|---|---|
| Founded | 2000 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2011 | 2013 |
| Metric | TRIP | BLFS |
|---|---|---|
| Price | $14.55 | $31.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 1 |
| Target Price | $14.40 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 2.6M | 1.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 675.00 | 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $1,556,000,000.00 | $96,214,000.00 |
| Revenue This Year | $3.33 | $19.73 |
| Revenue Next Year | $5.12 | $17.82 |
| P/E Ratio | ★ N/A | $1,489.50 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $9.01 | $17.86 |
| 52 Week High | $20.16 | $32.23 |
| Indicator | TRIP | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 67.54 |
| Support Level | $13.04 | $23.86 |
| Resistance Level | $15.33 | N/A |
| Average True Range (ATR) | 0.57 | 1.26 |
| MACD | -0.08 | 0.11 |
| Stochastic Oscillator | 75.41 | 92.79 |
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025, and TheFork, its dining brand, represented 12% of sales.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.